TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7099731

Group type: EXPERIMENTAL
Intervention: Methylphenidate (dosage adjusted based on nervous system classification)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31936720

Group type: EXPERIMENTAL
Intervention: Walnut consumption (Juglans regia L.) for 4 weeks
Number of subjects: 18
Study: 31823292

Group type: EXPERIMENTAL
Intervention: Early free‐spins
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Late free‐spins
Number of subjects: 188
Study: 29479695

Group type: EXPERIMENTAL
Intervention: Cost data presented using actual dollar amounts
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Cost data presented using the word 'affordable' for low-cost hospitals
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Readmission performance shown using word icons
Number of subjects: 420

Group type: COMPARATOR
Intervention: Hospital Compare spending ratio
Number of subjects: 420
Study: 26850418

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 100
Study: 24746755

Group type: EXPERIMENTAL
Intervention: Introitus group (held for 2 min at the level of the vagina)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Abdomen group (held on the mother's abdomen or chest)
Number of subjects: 546
Study: 22183214

Group type: EXPERIMENTAL
Intervention: 0.3 mg synthetic conjugated estrogens-B
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: 0.625 mg synthetic conjugated estrogens-B
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 20815158

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Beta blockers (Propranolol, Atenolol, Pindolol)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (Healthy volunteers)
Number of subjects: 225
Study: 17513033

Group type: EXPERIMENTAL
Intervention: Group D (one short unidirectional FRC prepregs placed on the main prepregs at 90 degrees)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group A (control group: two prepregs of unidirectional glass FRC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group B (two prepregs in pontic portion covered with one layer of multidirectional fiber veil FRC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group C (FRC prepregs covered in pontic portion with four short unidirectional FRC pieces)
Number of subjects: 48
Study: 15814542

Group type: EXPERIMENTAL
Intervention: Polysulphone (PS) dialysis membrane
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Regenerated cellulose (RC) dialysis membrane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of PS and RC membranes
Number of subjects: 8
Study: 12108501

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (ICDs)
Number of subjects: 0
Study: 9453014

Group type: EXPERIMENTAL
Intervention: Beta-blocker (BBL)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker (CCB)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Converting enzyme inhibitor (CEI)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Alpha-blocker (ABL)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Moxonidine (MOX)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study: 7615046

Group type: EXPERIMENTAL
Intervention: Mitoxantrone, Etoposide, and Ara-C (MEA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Doxorubicin-DNA, Ara-C, Thioguanine, Vincristine, and Prednisolone (POCAL-DNA)
Number of subjects: 86
Study: 2565265

Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 60 mg terfenadine
Number of subjects: 81

Group type: COMPARATOR
Intervention: 10 mg astemizole
Number of subjects: 81
Study: 1175125

Group type: EXPERIMENTAL
Intervention: MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone)
Number of subjects: 108

Group type: COMPARATOR
Intervention: HN2 (nitrogen mustard)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: MOPP
Number of subjects: 108

Group type: COMPARATOR
Intervention: HN2
Number of subjects: 108
Study: 31619335

Group type: EXPERIMENTAL
Intervention: Medetomidine (bolus dose, 5 μg kg‐1; CRI, 3.5 μg kg‐1 hour‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Detomidine (bolus dose, 10 μg kg‐1; CRI, 6 μg kg‐1 hour‐1)
Number of subjects: 50
Study: 31554370

Group type: EXPERIMENTAL
Intervention: Piperacillin/Tazobactam (PIP/TZO) 320 mg/kg/day divided every 8 hours
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ceftazidime 100 mg/kg/day divided every 8 hours plus Amikacin 15 mg/kg/day once daily
Number of subjects: 70
Study: 27522630

Group type: EXPERIMENTAL
Intervention: CA125-guided therapy (CA125 strategy)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 380
Study: 24492988

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 164
Study: 22717835

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 80

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 80
Study: 20861586

Group type: EXPERIMENTAL
Intervention: 60 mg NWP06 (extended-release methylphenidate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 30 mg immediate-release methylphenidate (IR MPH)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 60 mg NWP06
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both NWP06 and IR MPH
Number of subjects: 30
Study: 18445142

Group type: EXPERIMENTAL
Intervention: Insulin sensitizers
Number of subjects: 74

Group type: COMPARATOR
Intervention: Diet and exercise programme
Number of subjects: 74
Study: 16422874

Group type: EXPERIMENTAL
Intervention: On-demand tadalafil (20 mg)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Daily tadalafil (10 mg)
Number of subjects: 145
Study: 12660257

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation for IVF
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Oral contraception
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dehydrogesterone for endometrial luteal phase defect
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (two different regimens)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (healthy fertile women)
Number of subjects: 48
Study: 10618463

Group type: EXPERIMENTAL
Intervention: Chronic imipramine treatment
Number of subjects: 64
Study: 1862965

Group type: EXPERIMENTAL
Intervention: Multicomponent endotracheal anesthesia with controlled lung ventilation and postoperative intramuscular analgesia with non-narcotic and narcotic analgesics (Group I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epidural anesthesia with 2.5% trimecaine solution combined with adrenaline and small morphine doses at the upper thoracic segment level, with postoperative analgesia for 18 hours (Group II)
Number of subjects: 60
Study: 6412263

Group type: EXPERIMENTAL
Intervention: Bupropion (100, 200, 400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (15, 30 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30720444

Group type: EXPERIMENTAL
Intervention: 0.9% cadexomer iodine ointment plus standard care
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 0.9% cadexomer iodine powder plus standard care
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 124
Study: 30080085

Group type: EXPERIMENTAL
Intervention: PACT + EUC
Number of subjects: 36

Group type: COMPARATOR
Intervention: EUC
Number of subjects: 36
Study: 26613985

Group type: EXPERIMENTAL
Intervention: Dextrose gel
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 184
Study: 24642406

Group type: EXPERIMENTAL
Intervention: iA-CPR
Number of subjects: 4753

Group type: COMPARATOR
Intervention: M-CPR
Number of subjects: 4753
Study: 22042967

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20702523

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment for 12 months
Number of subjects: 46
Study: 18163919

Group type: EXPERIMENTAL
Intervention: Low-dose doxycycline (LDD) 20 mg twice a day for 10 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 16339329

Group type: EXPERIMENTAL
Intervention: Supervised exercise training (ET) including 3 months of low intensity exercise and 3 months of progressive resistance training (PRT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control (CTL) group performing a low intensity home exercise program
Number of subjects: 91
Study: 12667328

Group type: EXPERIMENTAL
Intervention: Digital colposcope (SLC‐2000)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Optical colposcope
Number of subjects: 196
Study: 9649964

Group type: EXPERIMENTAL
Intervention: Oral morphine (10, 30, 56, and 100 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: LY297802 (0.1, 0.3, 0.56, and 1 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7675376

Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms every 2 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intracervical PGE2 gel 0.5 mg administered at 6-hour intervals
Number of subjects: 0
Study: 2044014

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate 60 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 30 mg qid
Number of subjects: 0
Study: 7360088

Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bran
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31015374

Group type: EXPERIMENTAL
Intervention: Safe sleep intervention videos
Number of subjects: 1263
Study: 28474780

Group type: EXPERIMENTAL
Intervention: Abaloparatide-SC (80 mcg daily subcutaneous injections for 18 months)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1645
Study: 26940110

Group type: EXPERIMENTAL
Intervention: Telephone-based weight management and healthy lifestyle programme (6-month duration)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 24576893

Group type: EXPERIMENTAL
Intervention: 100 ml of 50% glucose only
Number of subjects: 10

Group type: COMPARATOR
Intervention: 10 units of insulin with 100 ml of 50% glucose (50 g)
Number of subjects: 10
Study: 22984785

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening using PSA testing
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening in Sweden
Number of subjects: 666
Study: 19916207

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 17523386

Group type: EXPERIMENTAL
Intervention: Allergovit 6-grass pollen preparation
Number of subjects: 154
Study: 14660217

Group type: EXPERIMENTAL
Intervention: Power grip
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lateral pinch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pulp pinch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maximal grip force exertion
Number of subjects: 20
Study: 11163780

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 0
Study: 9849475

Group type: EXPERIMENTAL
Intervention: Cisplatin 50 mg/m2 and cyclophosphamide 500 mg/m2 (CP) every 28 days for six courses
Number of subjects: 176

Group type: COMPARATOR
Intervention: Cisplatin 75 mg/m2 every 28 days for six courses
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Cisplatin 50 mg/m2 and cyclophosphamide 500 mg/m2 (CP)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Cisplatin 75 mg/m2
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Platinum-containing chemotherapy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Platinum-free regimens
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Platinum second-line therapy
Number of subjects: 176
Study: 8300993

Group type: EXPERIMENTAL
Intervention: Training with a combination of food models and life-sized food photographs (experimental group, n = 18)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Training with food models (control group, n = 26)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both training techniques (experimental and control)
Number of subjects: 44
Study: 2230213

Group type: EXPERIMENTAL
Intervention: Topical all‐trans retinoic acid (0.05%) applied to the forearms for 6 months
Number of subjects: 27

Group type: COMPARATOR
Intervention: Excipient alone (untreated forearm)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Topical all‐trans retinoic acid (0.05%)
Number of subjects: 27
Study: 116285

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 30
Study: 30369087

Group type: EXPERIMENTAL
Intervention: Mock recruitment protocol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Concerns raised during mock recruitment
Number of subjects: 45
Study: 28975305

Group type: EXPERIMENTAL
Intervention: Community health worker-led multicomponent intervention (health coaching, home BP monitoring, BP audit and feedback, physician intervention, text-messaging intervention) over 18 months
Number of subjects: 1432

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1432
Study: 25972260

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab
Number of subjects: 81

Group type: COMPARATOR
Intervention: ranibizumab plus laser
Number of subjects: 81

Group type: COMPARATOR
Intervention: ranibizumab
Number of subjects: 81
Study: 23343138

Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Telemonitoring (HBPT)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Conventional Management (CM)
Number of subjects: 252
Study: 21896561

Group type: EXPERIMENTAL
Intervention: Moxifloxacin iv 400 mg once daily followed by oral 400 mg once daily
Number of subjects: 813

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (TZP) iv 4.0/0.5 g thrice daily followed by oral amoxicillin/clavulanate (AMC) 875/125 mg twice daily
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Moxifloxacin iv/oral
Number of subjects: 813

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (TZP) iv followed by oral amoxicillin/clavulanate (AMC)
Number of subjects: 813
Study: 19969174

Group type: EXPERIMENTAL
Intervention: Retraining with the Dynavision apparatus for 18 sessions
Number of subjects: 26

Group type: COMPARATOR
Intervention: No intervention (waitlist)
Number of subjects: 26
Study: 17225260

Group type: EXPERIMENTAL
Intervention: Ovarian cancer screening and risk counseling
Number of subjects: 592

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Ovarian cancer screening with abnormal test results
Number of subjects: 592
Study: 15590951

Group type: EXPERIMENTAL
Intervention: Secondary surgical cytoreduction plus chemotherapy
Number of subjects: 550

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 550
Study: 11513442

Group type: EXPERIMENTAL
Intervention: Bachmann's bundle (BB) pacing
Number of subjects: 120

Group type: COMPARATOR
Intervention: Right atrial appendage (RAA) pacing
Number of subjects: 120
Study: 9587124

Group type: EXPERIMENTAL
Intervention: Early adjuvant radiation therapy (RT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Salvage radiation therapy (RT)
Number of subjects: 53
Study: 7834258

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 58

Group type: COMPARATOR
Intervention: Methohexital
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups (Propofol and Methohexital)
Number of subjects: 58
Study: 2499234

Group type: EXPERIMENTAL
Intervention: 100% O2
Number of subjects: 6

Group type: COMPARATOR
Intervention: 21% O2
Number of subjects: 6

Group type: COMPARATOR
Intervention: 40% O2
Number of subjects: 6
Study: 806293

Group type: COMPARATOR
Intervention: Disodium cromoglycate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Betamethasone 17 valerate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both drugs combined (disodium cromoglycate and betamethasone 17 valerate)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31888372

Group type: EXPERIMENTAL
Intervention: Kinematic alignment (KA)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Mechanical alignment (MA)
Number of subjects: 125
Study: 31268555

Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 0.5 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 1.0 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 2.0 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Staccato placebo
Number of subjects: 5
Study: 28718828

Group type: EXPERIMENTAL
Intervention: Vaporised nicotine products (VNPs) with up to 12 weeks’ supply of nicotine e‐liquid
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vaporised nicotine products (VNPs)
Number of subjects: 30
Study: 26024532

Group type: EXPERIMENTAL
Intervention: Clinical decision model (n = 219)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Usual care (n = 220)
Number of subjects: 439
Study: 23559064

Group type: EXPERIMENTAL
Intervention: active rTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 22
Study: 21121978

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurts containing Lactobacillus plantarum strains and Lactobacillus casei strain
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei Shirota
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CBS125632
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 62
Study: 19814793

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 16411999

Group type: EXPERIMENTAL
Intervention: Overlap repair with polyglactin (Vicryl)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: End-to-end repair with polyglactin (Vicryl)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overlap repair with polydioxanone (PDS)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: End-to-end repair with PDS
Number of subjects: 150

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 150
Study: 15223223

Group type: COMPARATOR
Intervention: Maternal diabetes
Number of subjects: 56492

Group type: COMPARATOR
Intervention: Paternal diabetes
Number of subjects: 56492

Group type: COMPARATOR
Intervention: Bilineal parental diabetes
Number of subjects: 56492

Group type: COMPARATOR
Intervention: No parental diabetes
Number of subjects: 56492
Study: 11504004

Group type: EXPERIMENTAL
Intervention: Adjusted word presentation interval for long and short words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard word presentation interval
Number of subjects: 0
Study: 9257202

Group type: EXPERIMENTAL
Intervention: OTFC premedication and halothane induction
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: OTFC premedication and propofol induction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo premedication and halothane induction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo premedication and propofol induction
Number of subjects: 62
Study: 8490981

Group type: EXPERIMENTAL
Intervention: Chloramphenicol alone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chloramphenicol + penicillin
Number of subjects: 70
Study: 3491791

Group type: EXPERIMENTAL
Intervention: Colistin and neomycin
Number of subjects: 105

Group type: COMPARATOR
Intervention: TMP-SMZ and colistin
Number of subjects: 105
Study: 29300971

Group type: EXPERIMENTAL
Intervention: Prognostic genicular nerve block
Number of subjects: 54

Group type: COMPARATOR
Intervention: No block
Number of subjects: 54
Study: 27437716

Group type: EXPERIMENTAL
Intervention: Abdominopelvic training by virtual reality (APT_VR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pelvic floor muscle training using a gym ball (PFMT_GB)
Number of subjects: 60
Study: 24079396

Group type: EXPERIMENTAL
Intervention: Motor imagery-based Brain Computer Interface (MI-based BCI) training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Functional Electrical Stimulation (FES) treatment
Number of subjects: 8
Study: 21800180

Group type: EXPERIMENTAL
Intervention: Vocational training immediately (Immediate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vocational training delayed (Delayed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Immediate and Delayed groups
Number of subjects: 0
Study: 20837948

Group type: COMPARATOR
Intervention: Gemcitabine (control arm)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gemcitabine-based chemoradiotherapy (CRT arm)
Number of subjects: 90
Study: 18270586

Group type: EXPERIMENTAL
Intervention: Newborn resuscitation training (NRT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (late training)
Number of subjects: 83
Study: 16160572

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) gel applied
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alloplastic graft material reconstituted with blood
Number of subjects: 20
Study: 12834649

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatments (CBT)
Number of subjects: 435

Group type: COMPARATOR
Intervention: History of major depressive disorder (MDD)
Number of subjects: 435

Group type: COMPARATOR
Intervention: History of alcohol dependence (AD)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Regression analyses
Number of subjects: 435
Study: 10825372

Group type: EXPERIMENTAL
Intervention: Mifepristone administration
Number of subjects: 6
Study: 8878385

Group type: EXPERIMENTAL
Intervention: FK506 (tacrolimus)
Number of subjects: 92